✦ LIBER ✦

A Randomized Clinical Trial of Immunization With Combined Hepatitis A and B Versus Hepatitis B Alone for Hepatitis B Seroprotection in Hemodialysis Patients

✍ Scribed by Jennifer Tung; Euan Carlisle; Marek Smieja; Peter T. Kim; Christine H. Lee

Book ID: 114469944
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 425 KB
Volume: 56
Category: Article
ISSN: 0272-6386
DOI: 10.1053/j.ajkd.2010.04.015

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hepatitis B vaccination in haemodialysis

Hepatitis B vaccination in haemodialysis patients: A randomized clinical trial

✍ MARILENE BOCK; ELVINO BARROS; FRANCISCO JV VERONESE 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB

The cost-effectiveness of using hepatiti

The cost-effectiveness of using hepatitis A/B combined vaccine versus hepatitis B vaccine alone for high-risk heterosexuals

✍ David B. Rein; Cindy M. Weinbaum 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 99 KB

A randomized controlled trial of thymosi

A randomized controlled trial of thymosin-α1 versus interferon alfa treatment in patients with hepatitis B e antigen antibody—and hepatitis B virus DNA—positive chronic hepatitis B

✍ P Andreone; C Cursaro; A Gramenzi; C Zavaglia; I Rezakovic; E Altomare; R Severi 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB 👁 1 views

ment for anti-HBe-positive chronic hepatitis. The benefit It has recently been shown that thymosin-a 1 (T-a 1 ), a of this agent in producing long-term inhibition of HBV synthetic polypeptide of thymic origin, is able to proreplication must be confirmed by future trials. (HEPAmote disease remission

A randomized controlled trial of thymosi

A randomized controlled trial of thymosin-alpha1 versus interferon alfa treatment in patients with hepatitis B e antigen antibody-and hepatitis B virus DNA-positive chronic hepatitis B

✍ P Andreone; C Cursaro; A Gramenzi; C Zavaglia; I Rezakovic; E Altomare; R Severi 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 190 KB

Comparison of a recombinant DNA hepatiti

Comparison of a recombinant DNA hepatitis B vaccine alone or in combination with hepatitis B immune globulin for the prevention of perinatal acquisition of hepatitis B carriage

✍ Y. Poovorawan; S. Sanpavat; W. Pongpunlet; S. Chumdermpadetsuk; P. Sentrakul; S. 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 381 KB

Early hepatitis B virus DNA reduction in

Early hepatitis B virus DNA reduction in hepatitis B e antigen–positive patients with chronic hepatitis B: A randomized international study of entecavir versus adefovir

✍ Nancy Leung; Cheng-Yuan Peng; Hie-Won Hann; Jose Sollano; Judy Lao-Tan; Chao-Wei 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 382 KB 👁 2 views

This study was undertaken to compare the early antiviral activity and viral kinetic profiles of entecavir (ETV) versus adefovir (ADV) in hepatitis B e antigen positive nucleoside-naïve adults with chronic hepatitis B (CHB). Sixty-nine nucleoside-naïve CHB patients with baseline HBV DNA of 10(8) copi